ResearcherImperial College LondonNo recent work listed

Elaina N. Maginn

Verified by OpenAlex author ID (good confidence)As of 10 November 2026

Matched on OpenAlex author ID A5052773854.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Collaborators: 3

Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper

Papers 2

Combined inhibition of the PI3K/mTOR/MEK pathway induces Bim/Mcl-1-regulated apoptosis in pancreatic cancer cells. Co-author DOI 10.1080/15384047.2018.1504718 ↗
Opportunities for translation: targeting DNA repair pathways in pancreatic cancer. First author DOI 10.1016/j.bbcan.2014.04.002 ↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Euan A. Stronach · 2 shared papers, 2014–2019
- Paper Combined inhibition of the PI3K/mTOR/MEK pathway induces Bim/Mcl-1-regulated apoptosis in pancreatic cancer cells. DOI 10.1080/15384047.2018.1504718 ↗
- Paper Opportunities for translation: targeting DNA repair pathways in pancreatic cancer. DOI 10.1016/j.bbcan.2014.04.002 ↗
Harpreet Singh Wasan · 2 shared papers, 2014–2019
- Paper Combined inhibition of the PI3K/mTOR/MEK pathway induces Bim/Mcl-1-regulated apoptosis in pancreatic cancer cells. DOI 10.1080/15384047.2018.1504718 ↗
- Paper Opportunities for translation: targeting DNA repair pathways in pancreatic cancer. DOI 10.1016/j.bbcan.2014.04.002 ↗
Rajpal S. Burmi · 1 shared paper, 2019
- Paper Combined inhibition of the PI3K/mTOR/MEK pathway induces Bim/Mcl-1-regulated apoptosis in pancreatic cancer cells. DOI 10.1080/15384047.2018.1504718 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.